10 major updates from NuVasive in the last 6 months

Written by Alan Condon | May 28, 2019 | Print  |

NuVasive has been making headlines this year with significant revenue growth and device FDA approvals. The company is also amid a leadership shift for continued growth in the future.

10 key updates to know:

1. NuVasive CEO J. Christopher Barry selected a new executive team to lead the company's next growth phase. Mr. Barry restructured the organization to include several executives that will report directly to him.

2. NuVasive's Precice Bone Transport System received FDA 510(k) and European CE mark approval. The Precice system is an all-internal system used for segmental bone loss treatment in the tibia and femur.

3. In February, NuVasive reported fourth quarter revenue increased 6.3 percent to $288.3 million. Full year revenue jumped 7.3 percent to $1.1 billion.

4. In the first quarter of 2019, NuVasive reported a 5.5 percent increase in revenue.  First quarter revenue hit $274.8 million, a 5.5 percent increase year over year. Gross profit hit $200.3 million and reported GAAP net income was $9.4 million.

5. NuVasive's Reline System — a posterior fixation technology designed to preserve and restore spinal alignment — received FDA 510(k) clearance.

6. Surgeons at hospitals across the U.S. completed the first cases using NuVasive's Cohere XLIF, a lateral porous PEEK implant for lateral lumbar interbody fusion and lateral single-position surgery.

7. NuVasive General Manager Dale Wolf told the Dayton Business Journal that the company's manufacturing facility in West Carrollton, Ohio, achieved several milestones in 2018 and plans to immediately build on that success.  

8. The company is in the process of developing a spinal robotics platform, Pulse, that can be applied to all spine surgeries as an end-t-end solution. NuVasive plans to debut the platform at the North American Spine Society annual meeting in September.

9. NuVasive introduced the X360 system, a lateral single-position spine surgery platform, at the American Association of Neurological Surgeons Annual Scientific Meeting April 13-17 in San Diego.

10. The company's LessRay radiation reduction and workflow enhancement platform received a gold-level award April 4 at the 2019 Edison Awards in New York City.

More articles on devices:
Colorado hospital installs Mako robot
16-year-old's spine surgery imaging platform wins $75K prize — 4 insights
The top 4 biggest players in the medical device field keep growing bigger — 8 key acquisitions

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months